CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A U.S. federal judge has ordered CVS Caremark, the pharmacy benefits arm of CVS Health, to pay $95 million over allegations ...

CVS Health and its subsidiaries have experienced a turbulent week in the courts. | Not long after the state of Louisiana sued ...

For CVS Health CVS, the key to building customer trust is to enhance access to life-changing medications and also make them affordable. Beginning July 1, the company’s Pharmacy Benefit Manager (“PBM”) ...

The U.S. secured a partial judgment in its favor on claims that CVS’s pharmacy benefit management subsidiary, Caremark, ...

CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that could ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...

Lawsuits were filed against CVS and its pharmacy benefit manager, accusing them of unfair practices and illegal lobbying.